Literature DB >> 19714726

Flow cytometry antibody screening using pooled red cells.

Dong Il Won1, Ok-Ju Jung, Yun Soo Lee, Sang Geol Kim, Jang Soo Suh.   

Abstract

BACKGROUND: For red cell alloantibody screening, the column agglutination technique (CAT) is used extensively, and flow cytometry (FC) screening has recently been demonstrated to be accurate, rapid, and cost effective. We attempted to determine whether the high sensitivity of FC allows pooling of screening red cells, which is generally not an acceptable technique in CAT.
METHODS: For FC screening, a commercial two-cell screening panel was utilized for the preparation of individual cells (CSi), as well as pooled cells diluted 1 in 2 (CSp), and 1 in 3 (CS1/3). Another panel was pooled from 120 randomly selected group O donors (RSp).
RESULTS: Comparing the endpoint titrations of serial dilutions, CS1/3 was found to be one dilution, on the average, less sensitive than CSi. In 33 CAT-positive patient samples, the sensitivities of CSi and CSp did not differ significantly without polyethylene glycol (PEG) (30/33, 26/33, respectively, P = 0.125), although they did differ significantly with PEG (32/33, 25/33, respectively, P = 0.016). The percentages of reactive cells among the total cells from RSp were roughly proportional to the relevant antigen frequencies of the local donors.
CONCLUSIONS: A trend toward reduced sensitivity was observed using pooled red cells, even via FC. Pooled cells from randomly selected group O donors may be employed as another method by which the characteristics of known antibodies might be assessed. (c) 2009 Clinical Cytometry Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19714726     DOI: 10.1002/cyto.b.20494

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  2 in total

1.  Effects of Neutralization by Soluble ABH Antigens Produced by Transplanted Kidneys From ABO-Incompatible Secretor Donors.

Authors:  Jieun Kim; Sinyoung Kim; In Sik Hwang; Jong Rak Choi; Jae Geun Lee; Yu Seun Kim; Myoung Soo Kim; Hyun Ok Kim
Journal:  Ann Lab Med       Date:  2017-05       Impact factor: 3.464

2.  Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.

Authors:  Mehmet Özen; Soner Yılmaz; Tülin Özkan; Yeşim Özer; Aliye Aysel Pekel; Asuman Sunguroğlu; Günhan Gürman; Önder Arslan
Journal:  Turk J Haematol       Date:  2017-05-23       Impact factor: 1.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.